Phaik Ju Teoh

562 total citations
15 papers, 406 citations indexed

About

Phaik Ju Teoh is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Phaik Ju Teoh has authored 15 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Oncology. Recurrent topics in Phaik Ju Teoh's work include Multiple Myeloma Research and Treatments (7 papers), RNA regulation and disease (6 papers) and Protein Degradation and Inhibitors (5 papers). Phaik Ju Teoh is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), RNA regulation and disease (6 papers) and Protein Degradation and Inhibitors (5 papers). Phaik Ju Teoh collaborates with scholars based in Singapore, United States and United Kingdom. Phaik Ju Teoh's co-authors include Wee Joo Chng, Tae‐Hoon Chung, Siok‐Bian Ng, Rafaël Fonseca, Sinto Sebastian, Junfang Yan, Ömer An, Leilei Chen, Wilson Wang and Melissa Ooi and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Phaik Ju Teoh

15 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phaik Ju Teoh Singapore 8 294 189 175 61 39 15 406
Matthew T. Witkowski United States 13 241 0.8× 149 0.8× 151 0.9× 105 1.7× 64 1.6× 27 493
William B. Donnellan United States 13 262 0.9× 207 1.1× 398 2.3× 183 3.0× 25 0.6× 47 620
Rawan Faramand United States 10 154 0.5× 210 1.1× 115 0.7× 57 0.9× 37 0.9× 37 375
Zohar Sachs United States 12 246 0.8× 83 0.4× 138 0.8× 73 1.2× 82 2.1× 36 383
Jing Christine Ye United States 7 89 0.3× 139 0.7× 82 0.5× 61 1.0× 30 0.8× 20 262
Dagmar Wider Germany 10 144 0.5× 141 0.7× 164 0.9× 83 1.4× 20 0.5× 27 301
Katherine E. Lindblad United States 10 217 0.7× 91 0.5× 127 0.7× 122 2.0× 70 1.8× 14 393
Andrea Pepper United Kingdom 8 121 0.4× 187 1.0× 96 0.5× 132 2.2× 26 0.7× 19 348
Lars Fransecky Germany 8 131 0.4× 104 0.6× 99 0.6× 33 0.5× 34 0.9× 14 267
Chung Hyo Kang South Korea 9 203 0.7× 224 1.2× 53 0.3× 71 1.2× 15 0.4× 12 348

Countries citing papers authored by Phaik Ju Teoh

Since Specialization
Citations

This map shows the geographic impact of Phaik Ju Teoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phaik Ju Teoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phaik Ju Teoh more than expected).

Fields of papers citing papers by Phaik Ju Teoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phaik Ju Teoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phaik Ju Teoh. The network helps show where Phaik Ju Teoh may publish in the future.

Co-authorship network of co-authors of Phaik Ju Teoh

This figure shows the co-authorship network connecting the top 25 collaborators of Phaik Ju Teoh. A scholar is included among the top collaborators of Phaik Ju Teoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phaik Ju Teoh. Phaik Ju Teoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Teoh, Phaik Ju, et al.. (2024). Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond. Haematologica. 110(5). 1074–1091. 1 indexed citations
2.
Chung, Tae‐Hoon, Jianbiao Zhou, Tze King Tan, et al.. (2024). The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma. Blood. 145(11). 1164–1181. 1 indexed citations
3.
Chong, Phyllis S.Y., Jing-Yuan Chooi, Phaik Ju Teoh, et al.. (2023). Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma. Cancer Research. 83(20). 3414–3427. 5 indexed citations
4.
5.
Teoh, Phaik Ju & Wee Joo Chng. (2021). CAR T-cell therapy in multiple myeloma: more room for improvement. Blood Cancer Journal. 11(4). 84–84. 126 indexed citations
6.
Teoh, Phaik Ju, et al.. (2021). IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification. 7 indexed citations
7.
Teoh, Phaik Ju, et al.. (2020). ADARs, RNA editing and more in hematological malignancies. Leukemia. 35(2). 346–359. 16 indexed citations
8.
Teoh, Phaik Ju, et al.. (2019). IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification. Haematologica. 105(5). 1391–1404. 43 indexed citations
9.
Teoh, Phaik Ju, Tae‐Hoon Chung, Ömer An, et al.. (2019). Synthetic lethality in multiple myeloma harboring double oncogenic hits of 17p13(del) and 1q21(amp). Clinical Lymphoma Myeloma & Leukemia. 19(10). e50–e51. 1 indexed citations
10.
Teoh, Phaik Ju, Ömer An, Tae‐Hoon Chung, et al.. (2019). ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS. Hematological Oncology. 37(S2). 549–549. 3 indexed citations
11.
Teoh, Phaik Ju, Ömer An, Tae‐Hoon Chung, et al.. (2018). Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood. 132(12). 1304–1317. 80 indexed citations
12.
Teoh, Phaik Ju, et al.. (2017). JMJD3 Is a Potential Tumor Suppressor Gene That Cooperates with TP53 in Chromosome 17p13. Blood. 130. 1761–1761. 1 indexed citations
13.
14.
Teoh, Phaik Ju, Tae‐Hoon Chung, Sinto Sebastian, et al.. (2014). p53 haploinsufficiency and functional abnormalities in multiple myeloma. Leukemia. 28(10). 2066–2074. 62 indexed citations
15.
Teoh, Phaik Ju & Wee Joo Chng. (2014). p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma. BioMed Research International. 2014. 1–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew T. Witkowski Breakdown of academic impact, for papers by William B. Donnellan Breakdown of academic impact, for papers by Rawan Faramand Breakdown of academic impact, for papers by Zohar Sachs Breakdown of academic impact, for papers by Jing Christine Ye Breakdown of academic impact, for papers by Dagmar Wider Breakdown of academic impact, for papers by Katherine E. Lindblad Breakdown of academic impact, for papers by Andrea Pepper Breakdown of academic impact, for papers by Lars Fransecky Breakdown of academic impact, for papers by Chung Hyo Kang
Rankless by CCL
2026